China Pharma Holdings, Inc. Income Statement

Income Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 74.39M81.17M54.51M32.81M22.13M20.35M15.57M13.21M12.33M10.92M10.87M9.64M8.10M7.01M4.53M
Cost of Revenue 44.11M52.18M38.66M23.41M17.22M15.78M12.35M10.74M10.36M9.44M8.91M9.29M8.60M7.29M6.51M
Gross Profit 30.28M28.99M14.08M-0.48M2.67M1.46M3.22M2.47M1.97M1.48M1.95M0.35M-0.49M-0.28M-1.99M
Operating items
Research & Development 0.44M1.68M2.80M0.96M0.37M0.09M0.17M0.23M0.38M0.32M0.19M0.24M0.28M
Selling, General & Administrative 3.04M3.72M2.87M2.40M1.72M1.90M2.27M2.02M1.95M2.29M1.82M1.65M1.89M1.47M1.78M
Other Operating Expenses 3.05M3.55M5.00M14.04M36.98M14.55M9.09M19.04M10.30M19.37M2.33M1.24M0.98M0.76M0.53M
Operating Expenses 6.09M7.26M8.31M18.13M41.49M17.40M11.72M21.15M12.42M21.89M4.53M3.21M3.06M2.47M2.60M
Operating Income 24.66M22.03M5.91M-18.61M-38.76M-14.30M-8.16M-18.68M-10.45M-20.41M-2.58M-2.86M-3.55M-2.75M-4.59M
EBIT 24.66M22.03M5.91M-18.61M-38.76M-14.30M-8.16M-18.68M-10.45M-20.41M-2.58M-2.86M-3.55M-2.75M-4.59M
Non-operating items
Interest & Investment Income 0.02M0.01M0.00M0.01M0.07M0.12M0.13M0.06M0.04M0.03M0.01M0.00M0.01M0.01M0.01M
Other Non Operating Income 1.59M0.93M0.07M1.64M0.34M
Non Operating Income 0.69M-0.30M-0.34M0.72M-1.05M-0.72M-0.47M-0.41M-0.29M-0.29M-0.54M-0.42M-0.33M-0.15M
Net income details
EBT 1.44M22.71M5.60M-18.95M-39.47M-15.35M-8.87M-19.15M-10.86M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Tax Provisions -2.69M-3.44M-0.98M-1.06M-0.08M-0.06M0.31M0.12M-0.18M
Profit After Tax 23.41M19.27M4.62M-20.01M-39.55M-15.41M-9.18M-19.28M-10.75M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Income from Continuing Operations 4.12M26.15M6.59M-17.89M-39.40M-15.28M-9.18M-19.28M-10.68M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Consolidated Net Income 4.12M26.15M6.59M-17.89M-39.40M-15.28M-9.18M-19.28M-10.68M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Income towards Parent Company 4.12M26.15M6.59M-17.89M-39.40M-15.28M-9.18M-19.28M-10.68M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Net Income towards Common Stockholders 4.12M26.15M6.59M-17.89M-39.40M-15.28M-9.18M-19.28M-10.68M-20.70M-2.87M-3.40M-3.97M-3.08M-4.74M
Additional items
EPS (Basic) 0.540.440.11-0.46-0.91-0.35-0.21-0.44-0.25-0.48-0.07-0.74-3.78-0.91-0.27
EPS (Weighted Average and Diluted) 0.540.440.11-0.46-0.91-0.35-0.91-0.27
Shares Outstanding (Weighted Average) 0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.09M0.10M0.66M1.93M
EBITDA 27.14M24.35M5.89M-18.61M-38.76M-14.30M-8.16M-15.84M-12.87M-20.44M-2.10M-3.18M-4.96M-3.20M-4.87M
Interest Expenses -0.17M-0.26M-0.31M-0.35M0.79M-1.17M0.85M0.54M0.45M0.32M0.29M0.54M0.43M0.03M0.03M
Tax Rate 5.60%0.20%0.39%1.64%